Association of Serum Uric Acid and Coronary Artery Disease in Premenopausal Women
Authors:
Open Access
- 3 September 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (9) , e106130
Abstract
To date, no study in the published literature has investigated the role of various serum uric acid (SUA) concentrations in the development of angiographically-proven coronary artery disease (CAD) in premenopausal women. Therefore, the aim of this study was to investigate the role SUA levels may play in the prevalence, severity, and prognosis of CAD in premenopausal women. This cross-sectional retrospective study included 607 premenopausal women who had undergone coronary angiography. The CAD diagnosis was based upon stenosis affecting ≥50% of the luminal diameter. Association of the SUA levels with CAD prevalence, severity, and clinical outcomes were assessed by statistical analysis. In total, 369 (60.8%) of the patients were diagnosed with CAD. The CAD patients had significantly higher SUA levels than those without CAD (5.3±1.9 vs. 4.8±1.7 mg/dL, P = 0.001). The SUA levels were found to be significantly associated with CAD prevalence (P = 0.013). Patients with higher levels of SUA also showed increased rates of multivessel disease and composite end-points, such as major adverse cardiac events. Furthermore, multivariate analysis identified abnormally high levels of uric acid (hyperuricemia) as an independent risk factor for CAD (OR 1.51 (1.11–2.53), P<0.05). The SUA levels are significantly associated with the prevalence of CAD. The SUA levels may be a predictor for incidence of major cardiovascular events in premenopausal women.Keywords
This publication has 28 references indexed in Scilit:
- Alterations in Platelet Function and Cell-Derived Microvesicles in Recently Menopausal Women: Relationship to Metabolic Syndrome and Atherogenic RiskJournal of Cardiovascular Translational Research, 2011
- Cholesteryl Ester Transfer Protein Polymorphism (TaqIB) Associates With Risk in Postinfarction Patients With High C-Reactive Protein and High-Density Lipoprotein Cholesterol LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Increased Coronary Heart Disease Risk Determined by High High-Density Lipoprotein Cholesterol and C-Reactive Protein: Modulation by Variation in the CETP GeneArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Hyperuricemia and coronary heart disease: A systematic review and meta‐analysisArthritis Care & Research, 2010
- High plasma high-density lipoprotein levels, very low cardiovascular risk profile, and subclinical carotid atherosclerosis in postmenopausal womenJournal of Clinical Lipidology, 2009
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- The paradox of dysfunctional high-density lipoproteinCurrent Opinion in Lipidology, 2007
- Role of uric acid in hypertension, renal disease, and metabolic syndrome.Cleveland Clinic Journal of Medicine, 2006
- Mechanisms of Disease: proatherogenic HDL—an evolving fieldNature Clinical Practice Endocrinology & Metabolism, 2006
- Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US womenAtherosclerosis, 2006